Meeting
2015 Genitourinary Cancers Symposium
ASCENDE-RT*: A multicenter, randomized trial of dose-escalated external beam radiation therapy (EBRT-B) versus low-dose-rate brachytherapy (LDR-B) for men with unfavorable-risk localized prostate cancer.
Authors
W. James Morris
BC Cancer Agency, Vancouver, BC, Canada
W. James Morris , Scott Tyldesley , Howard H Pai , Ross Halperin , Michael R. McKenzie , Graeme Duncan , Gerard Morton , Nevin Murray , Jeremy Hamm
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Clinical Trial Registration Number
NCT00175396
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 3)
DOI
10.1200/jco.2015.33.7_suppl.3
Abstract #
3
Poster Bd #
A7
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
First Author: Phillip John Gray
Poster
2012 Genitourinary Cancers Symposium
Tolerability of and biochemical control of permanent pd-103 brachytherapy followed by external beam radiotherapy for localized prostate adenocarcinoma.
First Author: Samuel M. Richter
Poster
2023 ASCO Genitourinary Cancers Symposium
Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).
First Author: Atsunori Yorozu
Poster
2022 ASCO Genitourinary Cancers Symposium
External beam radiation therapy with or without brachytherapy boost for low PSA, high-grade prostate cancer.
First Author: Benjamin Walker Fischer-Valuck